These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
350 related items for PubMed ID: 19183278
1. Mycolic acid methyltransferase, MmaA4, is necessary for thiacetazone susceptibility in Mycobacterium tuberculosis. Alahari A, Alibaud L, Trivelli X, Gupta R, Lamichhane G, Reynolds RC, Bishai WR, Guerardel Y, Kremer L. Mol Microbiol; 2009 Mar; 71(5):1263-77. PubMed ID: 19183278 [Abstract] [Full Text] [Related]
3. Synthesis, antitubercular activity and mechanism of resistance of highly effective thiacetazone analogues. Coxon GD, Craig D, Corrales RM, Vialla E, Gannoun-Zaki L, Kremer L. PLoS One; 2013 Mar; 8(1):e53162. PubMed ID: 23301038 [Abstract] [Full Text] [Related]
4. A common mechanism of inhibition of the Mycobacterium tuberculosis mycolic acid biosynthetic pathway by isoxyl and thiacetazone. Grzegorzewicz AE, Korduláková J, Jones V, Born SE, Belardinelli JM, Vaquié A, Gundi VA, Madacki J, Slama N, Laval F, Vaubourgeix J, Crew RM, Gicquel B, Daffé M, Morbidoni HR, Brennan PJ, Quémard A, McNeil MR, Jackson M. J Biol Chem; 2012 Nov 09; 287(46):38434-41. PubMed ID: 23002234 [Abstract] [Full Text] [Related]
6. The new tuberculosis drug Perchlozone® shows cross-resistance with thiacetazone. Gopal P, Dick T. Int J Antimicrob Agents; 2015 Apr 09; 45(4):430-3. PubMed ID: 25704063 [Abstract] [Full Text] [Related]
8. An ethA-ethR-deficient Mycobacterium bovis BCG mutant displays increased adherence to mammalian cells and greater persistence in vivo, which correlate with altered mycolic acid composition. Ang ML, Zainul Rahim SZ, Shui G, Dianiškova P, Madacki J, Lin W, Koh VH, Martinez Gomez JM, Sudarkodi S, Bendt A, Wenk M, Mikušová K, Korduláková J, Pethe K, Alonso S. Infect Immun; 2014 May 09; 82(5):1850-9. PubMed ID: 24566628 [Abstract] [Full Text] [Related]
12. The dual function of the Mycobacterium tuberculosis FadD32 required for mycolic acid biosynthesis. Léger M, Gavalda S, Guillet V, van der Rest B, Slama N, Montrozier H, Mourey L, Quémard A, Daffé M, Marrakchi H. Chem Biol; 2009 May 29; 16(5):510-9. PubMed ID: 19477415 [Abstract] [Full Text] [Related]
18. Further insight into S-adenosylmethionine-dependent methyltransferases: structural characterization of Hma, an enzyme essential for the biosynthesis of oxygenated mycolic acids in Mycobacterium tuberculosis. Boissier F, Bardou F, Guillet V, Uttenweiler-Joseph S, Daffé M, Quémard A, Mourey L. J Biol Chem; 2006 Feb 17; 281(7):4434-45. PubMed ID: 16356931 [Abstract] [Full Text] [Related]
19. Isoxyl activation is required for bacteriostatic activity against Mycobacterium tuberculosis. Korduláková J, Janin YL, Liav A, Barilone N, Dos Vultos T, Rauzier J, Brennan PJ, Gicquel B, Jackson M. Antimicrob Agents Chemother; 2007 Nov 17; 51(11):3824-9. PubMed ID: 17785510 [Abstract] [Full Text] [Related]
20. Temperature-dependent regulation of mycolic acid cyclopropanation in saprophytic mycobacteria: role of the Mycobacterium smegmatis 1351 gene (MSMEG_1351) in CIS-cyclopropanation of alpha-mycolates. Alibaud L, Alahari A, Trivelli X, Ojha AK, Hatfull GF, Guerardel Y, Kremer L. J Biol Chem; 2010 Jul 09; 285(28):21698-707. PubMed ID: 20457615 [Abstract] [Full Text] [Related] Page: [Next] [New Search]